REG - Develop North PLC - Change of Registered Office

Develop NorthAnnouncement

24/03/2026 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260324:nRSX9487Xa&default-theme=true

RNS Number : 9487X  Develop North PLC  24 March 2026

DEVELOP NORTH PLC
(the "Company" or "DVNO")

Change of Registered Office Address

 

The Company announces that, with effect from 21 March 2026, its registered
office address has changed to The Key, Bath Lane, Newcastle Helix, Newcastle
upon Tyne, NE4 5TQ.

 

24 March 2026

 

For further information regarding the Company (Ticker: DVNO) (LEI:
213800EXPWANYN3NEV68) please call:

 

 Develop North PLC                                                           +44 (0) 191 222 0099

Michelle Percy

 Ian McElroy
 Tier One Capital Limited (Investment Adviser)                               +44 (0) 191 222 0099

Brendan O'Grady
 Cavendish Capital Markets Limited (Financial Adviser and Corporate Broker)  +44 (0) 207 220 0500

Robert Peel

Andrew Worne

Oscar Valeur-Adu

 

 Apex Fund Administration Services (UK) Limited (Secretary)  +44 (0) 1245 398950

 

Notes to Editors:

 

Develop North PLC's investment objective is to provide shareholders with a
consistent and stable income and the potential for an attractive total return
over the medium to long term, through a diversified portfolio of investments
predominantly in the North East of England.

The Company has the financial strength, credibility and professionalism
expected of a business listed on the London Stock Exchange, while also
offering the flexibility, creativity and common sense of an approachable,
local business.

Since the Company's IPO in 2017, it has invested almost £90 million of
capital into the North of England and Scotland and has helped support an
estimate 12,000 jobs with a gross development value of more than £280
million.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CROFLFSSVSISFIR



            Copyright 2019 Regulatory News Service, all rights reserved